- Research works
- 13 ▲ 17% vs 2018-21
- Citations
- 531 42.4 per fractional work
- Top-10% rate
- 10.8% all institutions 10.0%
- Open access
- 62% world 40%
- International
- 69% world 18%
Not ranked overall: Biomay (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Biomay (Austria) work in?
In all years, 94% of research at Biomay (Austria) is in Health Sciences, 6% in Life Sciences. Its largest fields are Medicine (93%), Biochemistry, Genetics and Molecular Biology (5%), Environmental Science (1%). It does 2.5× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 5 fields, with their numbers
- Health Sciences1293.6%
- Medicine1293.3%
- Health Professions00.3%
- Life Sciences15.5%
- Physical Sciences00.9%
Who are the top researchers at Biomay (Austria)?
Ranked on the quality score, Frank Stolz, Angela Neubauer and Hans Gottlieb Huber lead among researchers whose main affiliation is Biomay (Austria).
- 1
Frank Stolz
Austria · #1,174,065 worldwide 2.7k citations · 50 works
- 2
Angela Neubauer
Austria · #1,445,740 worldwide 2.2k citations · 77 works
- 3
Hans Gottlieb Huber
Austria · #1,602,150 worldwide 2.7k citations · 104 works
Which research topics does Biomay (Austria) publish most on?
By volume in 2022-now: Food Allergy and Anaphylaxis Research, Allergic Rhinitis and Sensitization, SARS-CoV-2 detection and testing and Virus-based gene therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Food Allergy and Anaphylaxis Research Immunology and Allergy 0 works
- 2 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
- 3 SARS-CoV-2 detection and testing Infectious Diseases 0 works
- 4 Virus-based gene therapy research Genetics 0 works
- 5 Contact Dermatitis and Allergies Dermatology 0 works
- 6 RNA Interference and Gene Delivery Molecular Biology 0 works
- 7 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
- 8 S100 Proteins and Annexins Molecular Biology 0 works
- 9 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
- 10 Dermatology and Skin Diseases Dermatology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Biomay (Austria)'s research output changed?
Output in 2022-2025 was 17% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Biomay (Austria) as a percentage of every work published that year, 0.000013% in 2024.
Fractional works of Biomay (Austria) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Vienna
- University of Vienna
- TU Wien
- Medical University of Vienna
- Austrian Academy of Sciences
- BOKU University
- Vienna University of Economics and Business
- University of Veterinary Medicine Vienna
- Austrian Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Biomay (Austria). Posts are plain text and can be reported.